Study on efficacy of herbs used by tribes to treat snake bites begins

Chennai: In an effort to connect traditional wisdom with modern medicine, the Chennai Snake Park Trust along with the zoology department of Madras University has received a 30lakh grant from state govt to scientifically investigate the efficacy of herbs, long used by tribal communities for treating snake bite victims.

The three-year project aims to bridge the gap between indigenous remedies practiced for generations and formal scientific validation. Lead researcher Arulvasu from the department of Zoology will head the study in collaboration with the snake park research director and noted herpetologist, V Kalaiarasan. The research will involve isolating chemical compounds in selected herbs and testing them through both in vitro and in vivo animal models. If proven effective, these plant-based formulations could emerge as complementary treatments alongside conventional antivenin, offering new hope for better outcomes in snakebite victims.

The Irula tribals of Tamil Nadu have preserved this herbal knowledge as tightly guarded family traditions. “When bitten by a venomous snake, we mix and crush half a dozen herbs. The herbs used depend on the type of snake. These remedies are specific — different combinations for different species of snakes. Before giving the medicine, they check the victim’s pulse and condition,” an Irula tribal told TOI. This knowledge has been passed down generations, kept within families, and rarely shared with outsiders. “We usually do not reveal the names of the herbs. That is our way of preserving wisdom.”

The university and snake park are now coordinating with tribals to get information on the closely guarded secret. Experts say such an initiative is vital in a country such as India, which records the highest number of snakebite deaths globally every year. “Traditional remedies have played a lifesaving role for centuries, especially among rural and tribal populations who lacked access to hospitals or anti-venom serum. Science must step in to test their credibility,” said snake park executive chairman S Paulraj.

With the advance of allopathic medicine, even tribals increasingly rely on anti-venom serum in emergencies. But, this project add a valuable layer of defence in India’s fight against snakebite mortality, experts said.

Related Posts

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs